Baidu
map
CURR VASC PHARMACOL 润色咨询

Current Vascular Pharmacology

出版年份：2003 年文章数：542 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：10.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1225223, encodeId=c8e71225223b8, content=偏重的研究方向：血管药理<br>经验分享：请问没有动物实验有希望吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f008108824, createdName=ms6000000632854145, createdTime=Wed Jun 08 16:51:12 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087317, encodeId=11d1108e317c3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087318, encodeId=d6cd108e31824, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504679, encodeId=ced95046e941, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：这个领域就这样了，老领域，不会有大的改变的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540080, encodeId=6a7a540080f3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504616, encodeId=8d6c50461668, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492285, encodeId=8a664922852d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2022-06-08 ms6000000632854145

    偏重的研究方向：血管药理
    经验分享：请问没有动物实验有希望吗？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1225223, encodeId=c8e71225223b8, content=偏重的研究方向：血管药理<br>经验分享：请问没有动物实验有希望吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f008108824, createdName=ms6000000632854145, createdTime=Wed Jun 08 16:51:12 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087317, encodeId=11d1108e317c3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087318, encodeId=d6cd108e31824, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504679, encodeId=ced95046e941, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：这个领域就这样了，老领域，不会有大的改变的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540080, encodeId=6a7a540080f3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504616, encodeId=8d6c50461668, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492285, encodeId=8a664922852d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2021-12-28 msSSSSSD

    摘要和HIGHLIGHTS的区别？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1225223, encodeId=c8e71225223b8, content=偏重的研究方向：血管药理<br>经验分享：请问没有动物实验有希望吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f008108824, createdName=ms6000000632854145, createdTime=Wed Jun 08 16:51:12 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087317, encodeId=11d1108e317c3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087318, encodeId=d6cd108e31824, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504679, encodeId=ced95046e941, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：这个领域就这样了，老领域，不会有大的改变的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540080, encodeId=6a7a540080f3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504616, encodeId=8d6c50461668, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492285, encodeId=8a664922852d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2021-12-28 ms6000000264964247

    摘要一定要描述使用的方法么？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1225223, encodeId=c8e71225223b8, content=偏重的研究方向：血管药理<br>经验分享：请问没有动物实验有希望吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f008108824, createdName=ms6000000632854145, createdTime=Wed Jun 08 16:51:12 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087317, encodeId=11d1108e317c3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087318, encodeId=d6cd108e31824, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504679, encodeId=ced95046e941, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：这个领域就这样了，老领域，不会有大的改变的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540080, encodeId=6a7a540080f3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504616, encodeId=8d6c50461668, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492285, encodeId=8a664922852d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2014-07-30 匿名用户

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：这个领域就这样了，老领域，不会有大的改变的

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1225223, encodeId=c8e71225223b8, content=偏重的研究方向：血管药理<br>经验分享：请问没有动物实验有希望吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f008108824, createdName=ms6000000632854145, createdTime=Wed Jun 08 16:51:12 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087317, encodeId=11d1108e317c3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087318, encodeId=d6cd108e31824, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504679, encodeId=ced95046e941, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：这个领域就这样了，老领域，不会有大的改变的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540080, encodeId=6a7a540080f3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504616, encodeId=8d6c50461668, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492285, encodeId=8a664922852d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2017-07-18 yang_liping1

    虽然今年没有什么大变化，以后再看看

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1225223, encodeId=c8e71225223b8, content=偏重的研究方向：血管药理<br>经验分享：请问没有动物实验有希望吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f008108824, createdName=ms6000000632854145, createdTime=Wed Jun 08 16:51:12 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087317, encodeId=11d1108e317c3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087318, encodeId=d6cd108e31824, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504679, encodeId=ced95046e941, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：这个领域就这样了，老领域，不会有大的改变的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540080, encodeId=6a7a540080f3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504616, encodeId=8d6c50461668, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492285, encodeId=8a664922852d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2014-07-30 doctor680

    太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1225223, encodeId=c8e71225223b8, content=偏重的研究方向：血管药理<br>经验分享：请问没有动物实验有希望吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f008108824, createdName=ms6000000632854145, createdTime=Wed Jun 08 16:51:12 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087317, encodeId=11d1108e317c3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087318, encodeId=d6cd108e31824, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504679, encodeId=ced95046e941, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：这个领域就这样了，老领域，不会有大的改变的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540080, encodeId=6a7a540080f3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504616, encodeId=8d6c50461668, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492285, encodeId=8a664922852d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2012-11-28 qupeter

    明年能不能冲到3分？大家谈谈

    0

共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map